dihydropyridines

Preferred Label : dihydropyridines;

MeSH definition : Pyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position.;

Is substance : O;

Details

Origin ID

D004095;

UMLS CUI

C0012315;

ATC code(s)
- dihydropyridine derivatives [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- goe 5438 [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- Substance with dihydropyridine derivative structure and calcium channel blocker mechanism of action (substance) [SNOMED CT concept]
Record concept(s)
- dihydropyridines [MeSH concept]
Related MeSH Supplementary Concept(s)
- (N-(4-(2-hydroxy-3-(1-(2-chlorophenyl)piperazinyl)propoxy)-3-methoxy)benzyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine [MeSH Supplementary Concept]
- 1,2-dihydro-2-imino-4-(1-naphthylvinyl)-1-pyridineethanol [MeSH Supplementary Concept]
- 1,4-dihydro- 2,6-dimethyl-4-(2-(trifluoromethyl)phenyl)-3,5- pyridinedicarboxylic acid diethyl ester [MeSH Supplementary Concept]
- 1,4-dihydro--2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridinedicarboxylic acid 2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-3-(s-indacene)propionylamino)ethylethyl ester [MeSH Supplementary Concept]
- 1,4-dihydro-2,6-dimethyl-4-phenyl-3,5-pyridinecarboxylic acid dimethyl ester [MeSH Supplementary Concept]
- 1,4-dihydropyridine [MeSH Supplementary Concept]
- 1-(2-pyrimidinyl)-4-imino-1,4-dihydropyridine [MeSH Supplementary Concept]
- 1-(cyclopropylmethyl)-4-(4-((11)C)methoxyphenyl)-piperidin-1-yl-2-oxo-1,2-dihydropyridine-3-carbonitrile [MeSH Supplementary Concept]
- 1-butyl-4-(1H-inden-1-ylidene)-1,4-dihydropyridine [MeSH Supplementary Concept]
- 1-methyl-3-(N-(4-iodophenyl)carbamoyl)-1,4-dihydropyridine [MeSH Supplementary Concept]
- 1-methyl-3-(N-(4-iodophenylethyl)carbamoyl)-1,4-dihydropyridine [MeSH Supplementary Concept]
- 1-methyl-4-pentyl-1,4-dihydropyridine-3,5-dicarbaldehyde [MeSH Supplementary Concept]
- 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid monomethyl ester [MeSH Supplementary Concept]
- 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic hydroxyacetate [MeSH Supplementary Concept]
- 2,6-dimethyl-3,5-bis(2'-propoxyethoxycarbonyl)-4-(2''-difluoromethoxyphenyl)-1,4-dihydropyridine [MeSH Supplementary Concept]
- 2,6-dimethyl-3,5-dicarbomethoxy-4-(2-isothiocyano)phenyl-1,4-dihydropyridine [MeSH Supplementary Concept]
- 2,6-dimethyl-4-(2'-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester [MeSH Supplementary Concept]
- 2,6-dimethyl-4-(2-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid (2-(3-(4-benzoylphenyl)propionylamino)ethyl) ester ethyl ester [MeSH Supplementary Concept]
- 2,6-dimethyl-4-(3-O-benzyl-1,2-O-isopropylidene-beta-L-threo-pentofuranos-4-y)-1-phenyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester [MeSH Supplementary Concept]
- 2,6-dimethyl-4-furyl-1,4-dihydropyridine-5-dicarboxylate [MeSH Supplementary Concept]
- 2-hydroxypropylmethyl-1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate [MeSH Supplementary Concept]
- 2-nitrooxypropyl-3-nitrooxypropyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate [MeSH Supplementary Concept]
- 3'-azido-2',3'-dideoxy-5'-O-((1,4-dihydro-1-methyl-3-pyridyl)carbonyl)uridine [MeSH Supplementary Concept]
- 3,5-bis(methoxycarbonyl)-2,6,-dimethyl-4-(2-aminophenyl)-1,4-dihydropyridine [MeSH Supplementary Concept]
- 3,5-diacetyl-1,4-dihydrolutidine [MeSH Supplementary Concept]
- 3,5-dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine [MeSH Supplementary Concept]
- 3,5-dicyano-4-(5'-nitro-2'-furyl)-2,6-dimethyl-1,4-dihydropyridine [MeSH Supplementary Concept]
- 3-(1-(2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl)-3,6-dihydro-2H-pyridin-4-yl)-6-chloro-1H-indole [MeSH Supplementary Concept]
- 3-methyl 5-isopropyl 2-methoxyiminomethyl-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate [MeSH Supplementary Concept]
- 4,5-diethyl-3-(2-methoxyethylthio)-2-methyl-6-phenyl-1,4-dihydropyridine-3,5-dicarboxylate [MeSH Supplementary Concept]
- 4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-2-((2-hydroxyethoxy)methyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine [MeSH Supplementary Concept]
- 4-(4-hydroxy-3,5-bis(morpholin-4-ylmethyl)phenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester [MeSH Supplementary Concept]
- 5',4N-bis((1,4-dihydro-1-methyl-3-pyridinyl)carbonyl)-2',3'-dideoxycytosine [MeSH Supplementary Concept]
- 5'-(1,4-dihydro-1-methyl-3-pyridinylcarbonyl)-3'-azido-3'-deoxythymidine [MeSH Supplementary Concept]
- 5-(5,6-dihydro-4H-pyridin-3-ylidenemethyl)furan-2-yl)methanol [MeSH Supplementary Concept]
- 9-(3-iodo-4-methylphenyl)-5,9-dihydro-3H-furo(3,4-b)pyrano(4,3-e)pyridine-1,8(4H,7H)-dione [MeSH Supplementary Concept]
- AC 394 [MeSH Supplementary Concept]
- AE0047 [MeSH Supplementary Concept]
- AHC 52 [MeSH Supplementary Concept]
- AK 2-38 [MeSH Supplementary Concept]
- AN 1043 [MeSH Supplementary Concept]
- AN 406 [MeSH Supplementary Concept]
- AZD8330 [MeSH Supplementary Concept]
- B 874-67 [MeSH Supplementary Concept]
- B 9209-005 [MeSH Supplementary Concept]
- BAY 10-6735 [MeSH Supplementary Concept]
- BAY R3401 [MeSH Supplementary Concept]
- BAY y 5959 [MeSH Supplementary Concept]
- BBR 2160 [MeSH Supplementary Concept]
- BMS 193885 [MeSH Supplementary Concept]
- BMY 20064 [MeSH Supplementary Concept]
- BR-4628 [MeSH Supplementary Concept]
- CD 349 [MeSH Supplementary Concept]
- CGP-IOS [MeSH Supplementary Concept]
- CGS 27830 [MeSH Supplementary Concept]
- CP 220629 [MeSH Supplementary Concept]
- CRE 223 [MeSH Supplementary Concept]
- CV 159 [MeSH Supplementary Concept]
- DHP 218 [MeSH Supplementary Concept]
- DHP-014 [MeSH Supplementary Concept]
- DSR-98776 [MeSH Supplementary Concept]
- F 0401 [MeSH Supplementary Concept]
- FCE 24265 [MeSH Supplementary Concept]
- FPL 62129 [MeSH Supplementary Concept]
- FR 172516 [MeSH Supplementary Concept]
- GYKI 46544 [MeSH Supplementary Concept]
- H 160-51 [MeSH Supplementary Concept]
- ICI 153110 [MeSH Supplementary Concept]
- K-2-11 compound [MeSH Supplementary Concept]
- KV 1360 [MeSH Supplementary Concept]
- L 762459 [MeSH Supplementary Concept]
- LAU 0901 [MeSH Supplementary Concept]
- LF 2-0254 [MeSH Supplementary Concept]
- LY 249933 [MeSH Supplementary Concept]
- MDL 72567 [MeSH Supplementary Concept]
- MDL 72892 A-15 [MeSH Supplementary Concept]
- MRS 1097 [MeSH Supplementary Concept]
- MRS 1191 [MeSH Supplementary Concept]
- N-(1-phenylpropionyl)-4-(4-chlorophenyl)-1,2,3,6-tetrahydropyridine [MeSH Supplementary Concept]
- N-(1-phenylpropionyl)-4-(4-fluorophenyl)-1,2,3,6-tetrahydropyridine [MeSH Supplementary Concept]
- N-(2-(2-bromo-4-(3-cyano-2-methyl-5-oxo-7-propyl-1,4,5,6,7,8-hexahydroquinolin-4-yl)-6-ethoxyphenoxymethyl)-4,5-difluorophenyl)methanesulfonamide [MeSH Supplementary Concept]
- N-(4-((2-amino-3-chloropyridin-4-yl)oxy)-3-fluorophenyl)-5-(4-fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxamide [MeSH Supplementary Concept]
- N-(tert-butoxycarbonyl)-N-(4-(dimethylazaniumylidene)-1,4-dihydropyridin-1-ylsulfonyl)azanide [MeSH Supplementary Concept]
- N-acetylhystrine [MeSH Supplementary Concept]
- N-methyl-3-(tert-butyl)sulfinyl-1,4-dihydropyridine [MeSH Supplementary Concept]
- N-methylammodendrine [MeSH Supplementary Concept]
- NIK 250 [MeSH Supplementary Concept]
- NK 250 [MeSH Supplementary Concept]
- NK 252 [MeSH Supplementary Concept]
- NKY 722 [MeSH Supplementary Concept]
- NP 252 [MeSH Supplementary Concept]
- NPK 1867 [MeSH Supplementary Concept]
- NPK 1868 [MeSH Supplementary Concept]
- NPK 1886 [MeSH Supplementary Concept]
- OICR-9429 [MeSH Supplementary Concept]
- OSI 1210 [MeSH Supplementary Concept]
- OSI 3802 [MeSH Supplementary Concept]
- OSI-1190 [MeSH Supplementary Concept]
- OSI-2954 [MeSH Supplementary Concept]
- P 0285 [MeSH Supplementary Concept]
- PAK 200 [MeSH Supplementary Concept]
- PCA 4230 [MeSH Supplementary Concept]
- PCA 4233 [MeSH Supplementary Concept]
- PCA 4248 [MeSH Supplementary Concept]
- PCA 50922 [MeSH Supplementary Concept]
- PCA 50938 [MeSH Supplementary Concept]
- PCA 50941 [MeSH Supplementary Concept]
- PD 122860 [MeSH Supplementary Concept]
- RS 30026 [MeSH Supplementary Concept]
- RS 93522-004 [MeSH Supplementary Concept]
- RS 93522-004 bis(3,5-dinitrobenzoic acid ester) [MeSH Supplementary Concept]
- S 11568 [MeSH Supplementary Concept]
- S 312 [MeSH Supplementary Concept]
- SAN 202791 [MeSH Supplementary Concept]
- SDZ 207-180 [MeSH Supplementary Concept]
- SM 6586 [MeSH Supplementary Concept]
- SNAP 5540 [MeSH Supplementary Concept]
- STBODIPY dihydropyridine [MeSH Supplementary Concept]
- TC 81 [MeSH Supplementary Concept]
- TP0463518 [MeSH Supplementary Concept]
- UK 55444 [MeSH Supplementary Concept]
- UK-59811 [MeSH Supplementary Concept]
- XB 513 [MeSH Supplementary Concept]
- YM 15430-1 [MeSH Supplementary Concept]
- YM 16151-1 [MeSH Supplementary Concept]
- Z 6568 [MeSH Supplementary Concept]
- ZD0947 [MeSH Supplementary Concept]
- aranidipine [MeSH Supplementary Concept]
- aspernigrin A [MeSH Supplementary Concept]
- azelnidipine [MeSH Supplementary Concept]
- azidopine [MeSH Supplementary Concept]
- bay W 5035 [MeSH Supplementary Concept]
- bay w 9798 [MeSH Supplementary Concept]
- benidipine [MeSH Supplementary Concept]
- bimakalim [MeSH Supplementary Concept]
- cilnidipine [MeSH Supplementary Concept]
- clindpine [MeSH Supplementary Concept]
- desazadesferrithiocin [MeSH Supplementary Concept]
- desferrithiocin [MeSH Supplementary Concept]
- desmethyldesferrithiocin [MeSH Supplementary Concept]
- diazipine [MeSH Supplementary Concept]
- diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate [MeSH Supplementary Concept]
- diethyl 2,6-dimethyl-4-(2-(3-oxo-3-(tert-pentyloxy)prop-1-enyl)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate [MeSH Supplementary Concept]
- diethyl 2,6-dimethyl-4-(5-(1-naphthylethyl)-3-methylisoxazol-4-yl)-1,4-dihydropyridine-3,5-dicarboxylate [MeSH Supplementary Concept]
- diethyl 4-(4-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarboxylate [MeSH Supplementary Concept]
- dimethyl-1,4-dihydro-2,6-dimethyl-4-(4'-(4H-4-oxo-1-benzopyran-2-yl)phenyl)-3,5-pyridine dicarboxylate [MeSH Supplementary Concept]
- dimethyl-4-(2-chlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate [MeSH Supplementary Concept]
- efonidipine [MeSH Supplementary Concept]
- elgodipine [MeSH Supplementary Concept]
- embusartan [MeSH Supplementary Concept]
- ent-ketorfanol [MeSH Supplementary Concept]
- estradiol 17-dihydrotrigonelline [MeSH Supplementary Concept]
- etaftoron [MeSH Supplementary Concept]
- ethyl 4-(5'-nitro-2'-furyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate [MeSH Supplementary Concept]
- ethyl 6-chloro-5-formyl-2-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate [MeSH Supplementary Concept]
- ferrithiocin [MeSH Supplementary Concept]
- fluazifop [MeSH Supplementary Concept]
- fluodipine [MeSH Supplementary Concept]
- furnidipine [MeSH Supplementary Concept]
- glutapyrone [MeSH Supplementary Concept]
- labedipinedilol A [MeSH Supplementary Concept]
- lacidipine [MeSH Supplementary Concept]
- lercanidipine [MeSH Supplementary Concept]
- manidipine [MeSH Supplementary Concept]
- methyl 3-cyclopentyl-4,7-dihydro-1,6-dimethyl-4-(3-nitrophenyl)pyrazolo(3,4-b)pyridine-5-carboxylate [MeSH Supplementary Concept]
- methylpentyl-1,4-dihydro-2,6-dimehtyl-4-(3-nitrophenyl)-3,5-pydridinedicarboxylate [MeSH Supplementary Concept]
- milameline [MeSH Supplementary Concept]
- modipafant [MeSH Supplementary Concept]
- monomethyl 4-(2',3'-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-2,5-dicarboxylate [MeSH Supplementary Concept]
- niguldipine [MeSH Supplementary Concept]
- oxodipine [MeSH Supplementary Concept]
- pranidipine [MeSH Supplementary Concept]
- ro 18-3981 [MeSH Supplementary Concept]
- sadopine [MeSH Supplementary Concept]
- sch 00013 [MeSH Supplementary Concept]
- siderochelin A [MeSH Supplementary Concept]
- siderochelin C [MeSH Supplementary Concept]
- sodium 3,5-bis-ethoxycarbonyl-2,6,dimethyl-1,4-dihydropyridine-4-carboxylate [MeSH Supplementary Concept]
- stilbazolium merocyanine [MeSH Supplementary Concept]
- teludipine [MeSH Supplementary Concept]
- tiamdipine [MeSH Supplementary Concept]
- vanidipinedilol [MeSH Supplementary Concept]
- wy 27569 [MeSH Supplementary Concept]
- zanipress [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients